Evidence map›Paper›PMID 29415976›Full record

Trial reportJournal of clinical and experimental hematopathology : JCEH2018

Clinical management and outcomes of completely resected stage I follicular lymphoma.

Akihiko Yokohama, Yoko Hashimoto, Makiko Takizawa, Hiroaki Shimizu, Yuri Miyazawa, Akio Saitoh, Kohtaro Toyama, Takuma Ishizaki, Takeki Mitsui, Hiromi and 11 more

Open access · goldAbstract readClinical TrialMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of clinical and experimental hematopathology : JCEH, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Akihiko YokohamaBlood Transfusion Service, Gunma University Hospital, Faculty of Medicine, Gunma University, Maebashi, Gunma, Japan.
Yoko HashimotoDepartment of Hematology, Gunma University Graduate School of Medicine.
Makiko TakizawaDepartment of Hematology, Gunma University Graduate School of Medicine.
Hiroaki ShimizuDepartment of Hematology, Gunma University Graduate School of Medicine.
Yuri MiyazawaDivision of Hematology, National Hospital Organization Shibukawa Medical Center, Shibukawa, Gunma, Japan.
Akio SaitohDepartment of Hematology, Fujioka General Hospital, Fujioka, Gunma, Japan.
Kohtaro ToyamaDepartment of Hematology, Fujioka General Hospital, Fujioka, Gunma, Japan.
Takuma IshizakiDepartment of Hematology, Gunma University Graduate School of Medicine.
Takeki MitsuiDepartment of Hematology, Gunma University Graduate School of Medicine.
Hiromi
KoisoDepartment of Hematology, Gunma University Graduate School of Medicine.
Takayuki SaitohGunma University Graduate School of Health Sciences, Maebashi, Gunma, Japan.
Kayoko MurayamaDivision of Hematology and Oncology, Gunma Cancer Center, Ohta, Gunma, Japan.
Morio MatsumotoDivision of Hematology, National Hospital Organization Shibukawa Medical Center, Shibukawa, Gunma, Japan.
Morio SawamuraDivision of Hematology, National Hospital Organization Shibukawa Medical Center, Shibukawa, Gunma, Japan.
Hirokazu MurakamiGunma University Graduate School of Health Sciences, Maebashi, Gunma, Japan.
Junko HiratoClinical Department of Pathology, Gunma University Hospital, Maebashi, Gunma, Japan.
Masaru KojimaAnatomic and Diagnostic Pathology, Dokkyo University School of Medicine, Mibu, Tochigi, Japan.
Yoshihisa NojimaDepartment of Hematology, Gunma University Graduate School of Medicine.
Hiroshi HandaDepartment of Hematology, Gunma University Graduate School of Medicine.
Norifumi TsukamotoOncology Center, Gunma University Hospital, Maebashi, Gunma, Japan.
Gunma University · JPGunma University Hospital · JPNational Hospital Organization · JPDokkyo University · JPGunma Children's Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have revealed the clinical and biological features of stage I follicular lymphoma (FL), but information about patients with stage I FL who underwent total resection after tissue biopsy is limited. Among 305 FL patients diagnosed between 2001 and 2013, clinical stage I disease was observed in 36 patients. Of these, 18 patients underwent total resection after diagnostic tissue biopsy. We used

Indexed as

Lymphoma, FollicularPositron-Emission TomographyAgedDisease-Free SurvivalFemaleGlucose-6-PhosphateHumansMaleMiddle AgedNeoplasm, ResidualNeoplasm StagingSurvival Rate2-fluoro-2-deoxyglucose-6-phosphateGlucose-6-Phosphate18F-fluorodeoxyglucose PETfollicular lymphomairradiationresected

Identifiers

PMID29415976
PMCPMC6144197
OpenAlexW2788760162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.